Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-06-01 16:06:22 ET · period of report 2026-05-28 · accession 0001805688-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-01 16:06 | 2026-05-28 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | M - OptEx | $109.45 | +6,907 | 57.2K | +14% | +$756.0K |
| D | 2026-06-01 16:06 | 2026-05-28 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | S - Sale+OE | $235.41 | -6,907 | 50.3K | -12% | -$1.63M |
| D | 2026-06-01 16:06 | 2026-05-28 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | M - OptEx | $0.00 | -6,907 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-05-28 | M | A | 6,907 | $109.45 | 57,179 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-05-28 | S | D | 6,907 | $235.41 | 50,272 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-05-28 | M | D | 6,907 | $0.00 | 0 | D | $109.45 · — to 2030-05-06 | 6,907 Ordinary Shares | (F1) These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, 1/4th vested on the first anniversary of the vesting commencement date and the remainder vested in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2024. |